In vitro treatment of cardiomyocytes with PKG and PKA respectively reduced Fpassive in both AS groups, although the levels in treated diabetic AS patients remained elevated compared to those in non-diabetic AS patients, supporting the notion that diabetic AS patients exhibit more pronounced changes due to heightened oxidative stress and inflammatory responses. The gene discussed is PRKG1; the disease is aortic stenosis.